Countries Can More Safely Reopen Schools If Adults Limit Their Social Activities, Says WHO 15/09/2020 Grace Ren Countries may be able to reopen schools safely if adults strictly observe masking and social distancing measures, and show restraint in leisure activities, said World Health Organization Health Emergencies Executive Director Mike Ryan. “We have to reduce transmission at community level in order to lower the risk to those older and vulnerable people, and to […] Continue reading -> Non-Communicable Diseases & Injuries Are The Biggest Killers Of People In The Poorest Billion 15/09/2020 Grace Ren A new Lancet Commission reports shows for the first time that the main killers of the poorest billion people in the world aren’t traditional “diseases of poverty” such as tuberculosis or neglected tropical diseases, but are non-communicable disease such as heart diseases and stroke, and injuries. The Lancet NCDs and Injuries (NCDI) Poverty Commission found that these […] Continue reading -> United Nations General Assembly Adopts Resolution Calling For Holistic COVID-19 Response; United States & Israel Vote Against The Bloc 14/09/2020 Grace Ren The United Nations General Assembly adopted an omnibus resolution urging Member States to mount a coordinated global coronavirus response on 11 September. The resolution (Document A/74/L.92), submitted by the President of the Assembly Tijjani Muhammad-Bande, was almost passed unanimously, with only two countries voting against and two abstaining. United States & Israel Vote Against the […] Continue reading -> AstraZeneca COVID-19 Vaccine Trials Resume In the UK After Data Review Board Investigates Safety Signal 14/09/2020 Grace Ren AstraZeneca resumed clinical trials for its investigational COVID-19 vaccine Saturday, after briefly pausing the trial globally to investigate reports of a potential severe adverse in a patient in the United Kingdom. In a brief press release, AstraZeneca announced that Phase 3 trials for the vaccine, AZD1222, have resumed in the UK on 12 September following […] Continue reading -> COVID-19’s ‘Slow Burn’ – Africa’s Low Death Rate Puzzles Researchers 14/09/2020 Kerry Cullinan Cape Town, South Africa – Dire predictions of Africa being overwhelmed by a tsunami of COVID-19 infections and deaths have not materialized – yet – and this is confounding many researchers. So whether the reason is the continent’s youthful population, a certain level of “herd immunity” gained from prior exposure to other coronaviruses, or simply […] Continue reading -> COVID-19 May Change How Vaccines Are Sold & Distributed – But Can New Systems Really Achieve Global Access? 11/09/2020 Grace Ren COVID-19 has the potential to change how vaccines are sold and distributed, but industry leaders, academics, policymakers, and advocates are still struggling to decide the direction those changes should take. A successful COVID-19 vaccine should only be sold by companies to countries if it fits within an equitable distribution platform made by a neutral third […] Continue reading -> In COVID-19 Battle, Africa Needs To “Own” Its Public Health Space – Senior Africa CDC Official 10/09/2020 Paul Adepoju Ibadan, Nigeria – The pandemic has brought to the fore Africa’s reliance on international support for its health sector – and it is also challenging the continent’s ability to build up its resilience when donors fall through. “There is a new public health order that is coming because of COVID-19. COVID-19 has opened our eyes […] Continue reading -> AstraZeneca & Oxford University Suspend COVID-19 Vaccine Trial To Investigate Potential Severe Adverse Reaction 09/09/2020 Grace Ren AstraZeneca on Tuesday night suspended the Phase 3 trial of their experimental COVID-19 vaccine in order to investigate a a suspected severe adverse reaction in a volunteer reported in the United Kingdom. The trial suspension follows just on the heels of AstraZeneca’s chief executive officer’s pledge to seek regulatory approval for a COVID-19 vaccine only […] Continue reading -> Nine Biopharma Companies Sign Pledge To Safely Develop & Deploy A COVID-19 Vaccine 09/09/2020 Grace Ren The chief executive officers of nine biopharmaceutical companies at the forefront of the COVID-19 vaccine development race have signed a pledge to fully test the safety and efficacy of an investigational vaccine before rolling it out for mass use. The top executives of AstraZeneca, BioNTech, GlaxoKlineSmith, Johnson&Johnson, Merck, Moderna, Novavax, Sanofi, and Pfizer signed the […] Continue reading -> Stigma Blots Kenya’s COVID-19 War – Some Patients Fearful Of Seeking Treatment 08/09/2020 Maina Waruru Nairobi, Kenya – While banker Peter Karagu is one of the over 35,000 people who have contracted COVID-19 disease in Kenya over the past 6 months, he cannot in any way be described as an ordinary victim of the respiratory illness. Throughout his 22 days confined at an isolation ward at Kenyatta University Teaching Research […] Continue reading -> Posts navigation Older postsNewer posts
Non-Communicable Diseases & Injuries Are The Biggest Killers Of People In The Poorest Billion 15/09/2020 Grace Ren A new Lancet Commission reports shows for the first time that the main killers of the poorest billion people in the world aren’t traditional “diseases of poverty” such as tuberculosis or neglected tropical diseases, but are non-communicable disease such as heart diseases and stroke, and injuries. The Lancet NCDs and Injuries (NCDI) Poverty Commission found that these […] Continue reading -> United Nations General Assembly Adopts Resolution Calling For Holistic COVID-19 Response; United States & Israel Vote Against The Bloc 14/09/2020 Grace Ren The United Nations General Assembly adopted an omnibus resolution urging Member States to mount a coordinated global coronavirus response on 11 September. The resolution (Document A/74/L.92), submitted by the President of the Assembly Tijjani Muhammad-Bande, was almost passed unanimously, with only two countries voting against and two abstaining. United States & Israel Vote Against the […] Continue reading -> AstraZeneca COVID-19 Vaccine Trials Resume In the UK After Data Review Board Investigates Safety Signal 14/09/2020 Grace Ren AstraZeneca resumed clinical trials for its investigational COVID-19 vaccine Saturday, after briefly pausing the trial globally to investigate reports of a potential severe adverse in a patient in the United Kingdom. In a brief press release, AstraZeneca announced that Phase 3 trials for the vaccine, AZD1222, have resumed in the UK on 12 September following […] Continue reading -> COVID-19’s ‘Slow Burn’ – Africa’s Low Death Rate Puzzles Researchers 14/09/2020 Kerry Cullinan Cape Town, South Africa – Dire predictions of Africa being overwhelmed by a tsunami of COVID-19 infections and deaths have not materialized – yet – and this is confounding many researchers. So whether the reason is the continent’s youthful population, a certain level of “herd immunity” gained from prior exposure to other coronaviruses, or simply […] Continue reading -> COVID-19 May Change How Vaccines Are Sold & Distributed – But Can New Systems Really Achieve Global Access? 11/09/2020 Grace Ren COVID-19 has the potential to change how vaccines are sold and distributed, but industry leaders, academics, policymakers, and advocates are still struggling to decide the direction those changes should take. A successful COVID-19 vaccine should only be sold by companies to countries if it fits within an equitable distribution platform made by a neutral third […] Continue reading -> In COVID-19 Battle, Africa Needs To “Own” Its Public Health Space – Senior Africa CDC Official 10/09/2020 Paul Adepoju Ibadan, Nigeria – The pandemic has brought to the fore Africa’s reliance on international support for its health sector – and it is also challenging the continent’s ability to build up its resilience when donors fall through. “There is a new public health order that is coming because of COVID-19. COVID-19 has opened our eyes […] Continue reading -> AstraZeneca & Oxford University Suspend COVID-19 Vaccine Trial To Investigate Potential Severe Adverse Reaction 09/09/2020 Grace Ren AstraZeneca on Tuesday night suspended the Phase 3 trial of their experimental COVID-19 vaccine in order to investigate a a suspected severe adverse reaction in a volunteer reported in the United Kingdom. The trial suspension follows just on the heels of AstraZeneca’s chief executive officer’s pledge to seek regulatory approval for a COVID-19 vaccine only […] Continue reading -> Nine Biopharma Companies Sign Pledge To Safely Develop & Deploy A COVID-19 Vaccine 09/09/2020 Grace Ren The chief executive officers of nine biopharmaceutical companies at the forefront of the COVID-19 vaccine development race have signed a pledge to fully test the safety and efficacy of an investigational vaccine before rolling it out for mass use. The top executives of AstraZeneca, BioNTech, GlaxoKlineSmith, Johnson&Johnson, Merck, Moderna, Novavax, Sanofi, and Pfizer signed the […] Continue reading -> Stigma Blots Kenya’s COVID-19 War – Some Patients Fearful Of Seeking Treatment 08/09/2020 Maina Waruru Nairobi, Kenya – While banker Peter Karagu is one of the over 35,000 people who have contracted COVID-19 disease in Kenya over the past 6 months, he cannot in any way be described as an ordinary victim of the respiratory illness. Throughout his 22 days confined at an isolation ward at Kenyatta University Teaching Research […] Continue reading -> Posts navigation Older postsNewer posts
United Nations General Assembly Adopts Resolution Calling For Holistic COVID-19 Response; United States & Israel Vote Against The Bloc 14/09/2020 Grace Ren The United Nations General Assembly adopted an omnibus resolution urging Member States to mount a coordinated global coronavirus response on 11 September. The resolution (Document A/74/L.92), submitted by the President of the Assembly Tijjani Muhammad-Bande, was almost passed unanimously, with only two countries voting against and two abstaining. United States & Israel Vote Against the […] Continue reading -> AstraZeneca COVID-19 Vaccine Trials Resume In the UK After Data Review Board Investigates Safety Signal 14/09/2020 Grace Ren AstraZeneca resumed clinical trials for its investigational COVID-19 vaccine Saturday, after briefly pausing the trial globally to investigate reports of a potential severe adverse in a patient in the United Kingdom. In a brief press release, AstraZeneca announced that Phase 3 trials for the vaccine, AZD1222, have resumed in the UK on 12 September following […] Continue reading -> COVID-19’s ‘Slow Burn’ – Africa’s Low Death Rate Puzzles Researchers 14/09/2020 Kerry Cullinan Cape Town, South Africa – Dire predictions of Africa being overwhelmed by a tsunami of COVID-19 infections and deaths have not materialized – yet – and this is confounding many researchers. So whether the reason is the continent’s youthful population, a certain level of “herd immunity” gained from prior exposure to other coronaviruses, or simply […] Continue reading -> COVID-19 May Change How Vaccines Are Sold & Distributed – But Can New Systems Really Achieve Global Access? 11/09/2020 Grace Ren COVID-19 has the potential to change how vaccines are sold and distributed, but industry leaders, academics, policymakers, and advocates are still struggling to decide the direction those changes should take. A successful COVID-19 vaccine should only be sold by companies to countries if it fits within an equitable distribution platform made by a neutral third […] Continue reading -> In COVID-19 Battle, Africa Needs To “Own” Its Public Health Space – Senior Africa CDC Official 10/09/2020 Paul Adepoju Ibadan, Nigeria – The pandemic has brought to the fore Africa’s reliance on international support for its health sector – and it is also challenging the continent’s ability to build up its resilience when donors fall through. “There is a new public health order that is coming because of COVID-19. COVID-19 has opened our eyes […] Continue reading -> AstraZeneca & Oxford University Suspend COVID-19 Vaccine Trial To Investigate Potential Severe Adverse Reaction 09/09/2020 Grace Ren AstraZeneca on Tuesday night suspended the Phase 3 trial of their experimental COVID-19 vaccine in order to investigate a a suspected severe adverse reaction in a volunteer reported in the United Kingdom. The trial suspension follows just on the heels of AstraZeneca’s chief executive officer’s pledge to seek regulatory approval for a COVID-19 vaccine only […] Continue reading -> Nine Biopharma Companies Sign Pledge To Safely Develop & Deploy A COVID-19 Vaccine 09/09/2020 Grace Ren The chief executive officers of nine biopharmaceutical companies at the forefront of the COVID-19 vaccine development race have signed a pledge to fully test the safety and efficacy of an investigational vaccine before rolling it out for mass use. The top executives of AstraZeneca, BioNTech, GlaxoKlineSmith, Johnson&Johnson, Merck, Moderna, Novavax, Sanofi, and Pfizer signed the […] Continue reading -> Stigma Blots Kenya’s COVID-19 War – Some Patients Fearful Of Seeking Treatment 08/09/2020 Maina Waruru Nairobi, Kenya – While banker Peter Karagu is one of the over 35,000 people who have contracted COVID-19 disease in Kenya over the past 6 months, he cannot in any way be described as an ordinary victim of the respiratory illness. Throughout his 22 days confined at an isolation ward at Kenyatta University Teaching Research […] Continue reading -> Posts navigation Older postsNewer posts
AstraZeneca COVID-19 Vaccine Trials Resume In the UK After Data Review Board Investigates Safety Signal 14/09/2020 Grace Ren AstraZeneca resumed clinical trials for its investigational COVID-19 vaccine Saturday, after briefly pausing the trial globally to investigate reports of a potential severe adverse in a patient in the United Kingdom. In a brief press release, AstraZeneca announced that Phase 3 trials for the vaccine, AZD1222, have resumed in the UK on 12 September following […] Continue reading -> COVID-19’s ‘Slow Burn’ – Africa’s Low Death Rate Puzzles Researchers 14/09/2020 Kerry Cullinan Cape Town, South Africa – Dire predictions of Africa being overwhelmed by a tsunami of COVID-19 infections and deaths have not materialized – yet – and this is confounding many researchers. So whether the reason is the continent’s youthful population, a certain level of “herd immunity” gained from prior exposure to other coronaviruses, or simply […] Continue reading -> COVID-19 May Change How Vaccines Are Sold & Distributed – But Can New Systems Really Achieve Global Access? 11/09/2020 Grace Ren COVID-19 has the potential to change how vaccines are sold and distributed, but industry leaders, academics, policymakers, and advocates are still struggling to decide the direction those changes should take. A successful COVID-19 vaccine should only be sold by companies to countries if it fits within an equitable distribution platform made by a neutral third […] Continue reading -> In COVID-19 Battle, Africa Needs To “Own” Its Public Health Space – Senior Africa CDC Official 10/09/2020 Paul Adepoju Ibadan, Nigeria – The pandemic has brought to the fore Africa’s reliance on international support for its health sector – and it is also challenging the continent’s ability to build up its resilience when donors fall through. “There is a new public health order that is coming because of COVID-19. COVID-19 has opened our eyes […] Continue reading -> AstraZeneca & Oxford University Suspend COVID-19 Vaccine Trial To Investigate Potential Severe Adverse Reaction 09/09/2020 Grace Ren AstraZeneca on Tuesday night suspended the Phase 3 trial of their experimental COVID-19 vaccine in order to investigate a a suspected severe adverse reaction in a volunteer reported in the United Kingdom. The trial suspension follows just on the heels of AstraZeneca’s chief executive officer’s pledge to seek regulatory approval for a COVID-19 vaccine only […] Continue reading -> Nine Biopharma Companies Sign Pledge To Safely Develop & Deploy A COVID-19 Vaccine 09/09/2020 Grace Ren The chief executive officers of nine biopharmaceutical companies at the forefront of the COVID-19 vaccine development race have signed a pledge to fully test the safety and efficacy of an investigational vaccine before rolling it out for mass use. The top executives of AstraZeneca, BioNTech, GlaxoKlineSmith, Johnson&Johnson, Merck, Moderna, Novavax, Sanofi, and Pfizer signed the […] Continue reading -> Stigma Blots Kenya’s COVID-19 War – Some Patients Fearful Of Seeking Treatment 08/09/2020 Maina Waruru Nairobi, Kenya – While banker Peter Karagu is one of the over 35,000 people who have contracted COVID-19 disease in Kenya over the past 6 months, he cannot in any way be described as an ordinary victim of the respiratory illness. Throughout his 22 days confined at an isolation ward at Kenyatta University Teaching Research […] Continue reading -> Posts navigation Older postsNewer posts
COVID-19’s ‘Slow Burn’ – Africa’s Low Death Rate Puzzles Researchers 14/09/2020 Kerry Cullinan Cape Town, South Africa – Dire predictions of Africa being overwhelmed by a tsunami of COVID-19 infections and deaths have not materialized – yet – and this is confounding many researchers. So whether the reason is the continent’s youthful population, a certain level of “herd immunity” gained from prior exposure to other coronaviruses, or simply […] Continue reading -> COVID-19 May Change How Vaccines Are Sold & Distributed – But Can New Systems Really Achieve Global Access? 11/09/2020 Grace Ren COVID-19 has the potential to change how vaccines are sold and distributed, but industry leaders, academics, policymakers, and advocates are still struggling to decide the direction those changes should take. A successful COVID-19 vaccine should only be sold by companies to countries if it fits within an equitable distribution platform made by a neutral third […] Continue reading -> In COVID-19 Battle, Africa Needs To “Own” Its Public Health Space – Senior Africa CDC Official 10/09/2020 Paul Adepoju Ibadan, Nigeria – The pandemic has brought to the fore Africa’s reliance on international support for its health sector – and it is also challenging the continent’s ability to build up its resilience when donors fall through. “There is a new public health order that is coming because of COVID-19. COVID-19 has opened our eyes […] Continue reading -> AstraZeneca & Oxford University Suspend COVID-19 Vaccine Trial To Investigate Potential Severe Adverse Reaction 09/09/2020 Grace Ren AstraZeneca on Tuesday night suspended the Phase 3 trial of their experimental COVID-19 vaccine in order to investigate a a suspected severe adverse reaction in a volunteer reported in the United Kingdom. The trial suspension follows just on the heels of AstraZeneca’s chief executive officer’s pledge to seek regulatory approval for a COVID-19 vaccine only […] Continue reading -> Nine Biopharma Companies Sign Pledge To Safely Develop & Deploy A COVID-19 Vaccine 09/09/2020 Grace Ren The chief executive officers of nine biopharmaceutical companies at the forefront of the COVID-19 vaccine development race have signed a pledge to fully test the safety and efficacy of an investigational vaccine before rolling it out for mass use. The top executives of AstraZeneca, BioNTech, GlaxoKlineSmith, Johnson&Johnson, Merck, Moderna, Novavax, Sanofi, and Pfizer signed the […] Continue reading -> Stigma Blots Kenya’s COVID-19 War – Some Patients Fearful Of Seeking Treatment 08/09/2020 Maina Waruru Nairobi, Kenya – While banker Peter Karagu is one of the over 35,000 people who have contracted COVID-19 disease in Kenya over the past 6 months, he cannot in any way be described as an ordinary victim of the respiratory illness. Throughout his 22 days confined at an isolation ward at Kenyatta University Teaching Research […] Continue reading -> Posts navigation Older postsNewer posts
COVID-19 May Change How Vaccines Are Sold & Distributed – But Can New Systems Really Achieve Global Access? 11/09/2020 Grace Ren COVID-19 has the potential to change how vaccines are sold and distributed, but industry leaders, academics, policymakers, and advocates are still struggling to decide the direction those changes should take. A successful COVID-19 vaccine should only be sold by companies to countries if it fits within an equitable distribution platform made by a neutral third […] Continue reading -> In COVID-19 Battle, Africa Needs To “Own” Its Public Health Space – Senior Africa CDC Official 10/09/2020 Paul Adepoju Ibadan, Nigeria – The pandemic has brought to the fore Africa’s reliance on international support for its health sector – and it is also challenging the continent’s ability to build up its resilience when donors fall through. “There is a new public health order that is coming because of COVID-19. COVID-19 has opened our eyes […] Continue reading -> AstraZeneca & Oxford University Suspend COVID-19 Vaccine Trial To Investigate Potential Severe Adverse Reaction 09/09/2020 Grace Ren AstraZeneca on Tuesday night suspended the Phase 3 trial of their experimental COVID-19 vaccine in order to investigate a a suspected severe adverse reaction in a volunteer reported in the United Kingdom. The trial suspension follows just on the heels of AstraZeneca’s chief executive officer’s pledge to seek regulatory approval for a COVID-19 vaccine only […] Continue reading -> Nine Biopharma Companies Sign Pledge To Safely Develop & Deploy A COVID-19 Vaccine 09/09/2020 Grace Ren The chief executive officers of nine biopharmaceutical companies at the forefront of the COVID-19 vaccine development race have signed a pledge to fully test the safety and efficacy of an investigational vaccine before rolling it out for mass use. The top executives of AstraZeneca, BioNTech, GlaxoKlineSmith, Johnson&Johnson, Merck, Moderna, Novavax, Sanofi, and Pfizer signed the […] Continue reading -> Stigma Blots Kenya’s COVID-19 War – Some Patients Fearful Of Seeking Treatment 08/09/2020 Maina Waruru Nairobi, Kenya – While banker Peter Karagu is one of the over 35,000 people who have contracted COVID-19 disease in Kenya over the past 6 months, he cannot in any way be described as an ordinary victim of the respiratory illness. Throughout his 22 days confined at an isolation ward at Kenyatta University Teaching Research […] Continue reading -> Posts navigation Older postsNewer posts
In COVID-19 Battle, Africa Needs To “Own” Its Public Health Space – Senior Africa CDC Official 10/09/2020 Paul Adepoju Ibadan, Nigeria – The pandemic has brought to the fore Africa’s reliance on international support for its health sector – and it is also challenging the continent’s ability to build up its resilience when donors fall through. “There is a new public health order that is coming because of COVID-19. COVID-19 has opened our eyes […] Continue reading -> AstraZeneca & Oxford University Suspend COVID-19 Vaccine Trial To Investigate Potential Severe Adverse Reaction 09/09/2020 Grace Ren AstraZeneca on Tuesday night suspended the Phase 3 trial of their experimental COVID-19 vaccine in order to investigate a a suspected severe adverse reaction in a volunteer reported in the United Kingdom. The trial suspension follows just on the heels of AstraZeneca’s chief executive officer’s pledge to seek regulatory approval for a COVID-19 vaccine only […] Continue reading -> Nine Biopharma Companies Sign Pledge To Safely Develop & Deploy A COVID-19 Vaccine 09/09/2020 Grace Ren The chief executive officers of nine biopharmaceutical companies at the forefront of the COVID-19 vaccine development race have signed a pledge to fully test the safety and efficacy of an investigational vaccine before rolling it out for mass use. The top executives of AstraZeneca, BioNTech, GlaxoKlineSmith, Johnson&Johnson, Merck, Moderna, Novavax, Sanofi, and Pfizer signed the […] Continue reading -> Stigma Blots Kenya’s COVID-19 War – Some Patients Fearful Of Seeking Treatment 08/09/2020 Maina Waruru Nairobi, Kenya – While banker Peter Karagu is one of the over 35,000 people who have contracted COVID-19 disease in Kenya over the past 6 months, he cannot in any way be described as an ordinary victim of the respiratory illness. Throughout his 22 days confined at an isolation ward at Kenyatta University Teaching Research […] Continue reading -> Posts navigation Older postsNewer posts
AstraZeneca & Oxford University Suspend COVID-19 Vaccine Trial To Investigate Potential Severe Adverse Reaction 09/09/2020 Grace Ren AstraZeneca on Tuesday night suspended the Phase 3 trial of their experimental COVID-19 vaccine in order to investigate a a suspected severe adverse reaction in a volunteer reported in the United Kingdom. The trial suspension follows just on the heels of AstraZeneca’s chief executive officer’s pledge to seek regulatory approval for a COVID-19 vaccine only […] Continue reading -> Nine Biopharma Companies Sign Pledge To Safely Develop & Deploy A COVID-19 Vaccine 09/09/2020 Grace Ren The chief executive officers of nine biopharmaceutical companies at the forefront of the COVID-19 vaccine development race have signed a pledge to fully test the safety and efficacy of an investigational vaccine before rolling it out for mass use. The top executives of AstraZeneca, BioNTech, GlaxoKlineSmith, Johnson&Johnson, Merck, Moderna, Novavax, Sanofi, and Pfizer signed the […] Continue reading -> Stigma Blots Kenya’s COVID-19 War – Some Patients Fearful Of Seeking Treatment 08/09/2020 Maina Waruru Nairobi, Kenya – While banker Peter Karagu is one of the over 35,000 people who have contracted COVID-19 disease in Kenya over the past 6 months, he cannot in any way be described as an ordinary victim of the respiratory illness. Throughout his 22 days confined at an isolation ward at Kenyatta University Teaching Research […] Continue reading -> Posts navigation Older postsNewer posts
Nine Biopharma Companies Sign Pledge To Safely Develop & Deploy A COVID-19 Vaccine 09/09/2020 Grace Ren The chief executive officers of nine biopharmaceutical companies at the forefront of the COVID-19 vaccine development race have signed a pledge to fully test the safety and efficacy of an investigational vaccine before rolling it out for mass use. The top executives of AstraZeneca, BioNTech, GlaxoKlineSmith, Johnson&Johnson, Merck, Moderna, Novavax, Sanofi, and Pfizer signed the […] Continue reading -> Stigma Blots Kenya’s COVID-19 War – Some Patients Fearful Of Seeking Treatment 08/09/2020 Maina Waruru Nairobi, Kenya – While banker Peter Karagu is one of the over 35,000 people who have contracted COVID-19 disease in Kenya over the past 6 months, he cannot in any way be described as an ordinary victim of the respiratory illness. Throughout his 22 days confined at an isolation ward at Kenyatta University Teaching Research […] Continue reading -> Posts navigation Older postsNewer posts
Stigma Blots Kenya’s COVID-19 War – Some Patients Fearful Of Seeking Treatment 08/09/2020 Maina Waruru Nairobi, Kenya – While banker Peter Karagu is one of the over 35,000 people who have contracted COVID-19 disease in Kenya over the past 6 months, he cannot in any way be described as an ordinary victim of the respiratory illness. Throughout his 22 days confined at an isolation ward at Kenyatta University Teaching Research […] Continue reading -> Posts navigation Older postsNewer posts